Zimmer Biomet Announces Fourth Quarter and Full-Year 2023 Financial Results

Fourth quarter net sales of $1.940 billion increased 6.3% and 6.1% on a constant currency1 basis Fourth quarter diluted earnings per share were $2.01; adjusted1 diluted earnings per share were $2.20 Full-year net sales of $7.394 billion increased 6.5% and 7.5% on a constant currency1…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.